Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus

scientific article

Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1086/651022
P932PMC publication ID2826557
P698PubMed publication ID20144042
P5875ResearchGate publication ID41418455

P50authorAntonio LanzavecchiaQ4776729
Matthew B. FriemanQ95658074
Ralph S. BaricQ63881333
Timothy P SheahanQ88410103
Davide CortiQ88540622
Eric DonaldsonQ90822619
Barry RockxQ92024521
P2860cites workEarly Upregulation of Acute Respiratory Distress Syndrome-Associated Cytokines Promotes Lethal Disease in an Aged-Mouse Model of Severe Acute Respiratory Syndrome Coronavirus InfectionQ27488870
Structural insights into immune recognition of the severe acute respiratory syndrome coronavirus S protein receptor binding domainQ27654446
Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutantsQ28768526
Monoclonal antibodies differentially affect the interaction between the hemagglutinin of H9 influenza virus escape mutants and sialic receptors.Q30343834
Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R.Q30356663
Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibodyQ33239031
Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathwayQ33383237
Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variantsQ33780455
Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farmsQ33987404
Structural studies on viral escape from antibody neutralizationQ34302612
SARS: epidemiologyQ34305467
Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study GroupQ34358628
Structure of SARS coronavirus spike receptor-binding domain complexed with receptorQ34451350
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodiesQ35901171
Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged miceQ35914462
Amino acid substitutions in the S2 subunit of mouse hepatitis virus variant V51 encode determinants of host range expansionQ36424092
Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challengeQ36498144
Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirusQ36845879
Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14Q36856186
Infectious bronchitis virus S2 gene sequence variability may affect S1 subunit specific antibody bindingQ38317680
A single amino acid substitution in the S1 and S2 Spike protein domains determines the neutralization escape phenotype of SARS-CoV.Q40073664
Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodiesQ40437929
Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2.Q42844863
Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV).Q47736945
An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirusQ47957009
Conserved amino acids W423 and N424 in receptor-binding domain of SARS-CoV are potential targets for therapeutic monoclonal antibodyQ79795066
Restoration of virulence of escape mutants of H5 and H9 influenza viruses by their readaptation to miceQ81266087
Human monoclonal antibodies to SARS-coronavirus inhibit infection by different mechanismsQ84549758
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectsevere acute respiratory syndromeQ103177
CoronaviridaeQ1134583
monoclonal antibodyQ422248
P304page(s)946-955
P577publication date2010-03-01
P1433published inJournal of Infectious DiseasesQ4051141
P1476titleEscape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus
P478volume201

Reverse relations

cites work (P2860)
Q36702376A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
Q28817689A decade after SARS: strategies for controlling emerging coronaviruses
Q98721217A genetic barcode of SARS-CoV-2 for monitoring global distribution of different clades during the COVID-19 pandemic
Q98776197A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
Q98778482A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes
Q38275790A structural view of coronavirus-receptor interactions
Q90391255An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections
Q96225681An approach towards development of monoclonal IgY antibodies against SARS CoV-2 spike protein (S) using phage display method: A review
Q26799080Anti-infective immunoadhesins from plants
Q33886371Comparative pathogenesis of three human and zoonotic SARS-CoV strains in cynomolgus macaques
Q99552342Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition
Q95300582Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
Q98720898Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding
Q51783750Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform.
Q34594139Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness
Q36440258Escape From Monoclonal Antibody Neutralization Affects Henipavirus Fitness In Vitro and In Vivo
Q95642362How did we get here? A short history of COVID-19 and other coronavirus-related epidemics
Q34491357Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing
Q40787125Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo
Q40041480Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus
Q33627189Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution
Q24810360Immunogenetic mechanisms driving norovirus GII.4 antigenic variation
Q36154930Increased antibody affinity confers broad in vitro protection against escape mutants of severe acute respiratory syndrome coronavirus
Q91900087Monoclonal antibodies for prophylactic and therapeutic use against viral infections
Q38078178Monoclonal antibodies for prophylactic and therapeutic use against viral infections.
Q37929687Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential
Q56777344Novel neutralizing monoclonal antibodies protect rodents against lethal filovirus challenges
Q39614881Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus
Q35865538Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection
Q64118341Recent Aspects on the Pathogenesis Mechanism, Animal Models and Novel Therapeutic Interventions for Middle East Respiratory Syndrome Coronavirus Infections
Q47162709Receptor-binding loops in alphacoronavirus adaptation and evolution
Q35815644Reconstitution of the receptor-binding motif of the SARS coronavirus
Q35009468Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation
Q35612506SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission
Q96030625SARS-CoV-2 and COVID-19: A genetic, epidemiological, and evolutionary perspective
Q36710396SARS-like WIV1-CoV poised for human emergence
Q64993888Sequential Emergence and Wide Spread of Neutralization Escape Middle East Respiratory Syndrome Coronavirus Mutants, South Korea, 2015.
Q36736237Spread of Mutant Middle East Respiratory Syndrome Coronavirus with Reduced Affinity to Human CD26 during the South Korean Outbreak
Q87973551Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Q88974655Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Q94452368The trinity of COVID-19: immunity, inflammation and intervention
Q38044156Viral fitness: definitions, measurement, and current insights
Q47253371Viral metagenomics, protein structure, and reverse genetics: Key strategies for investigating coronaviruses